Abstract. We report that Bim has an apoptotic function through Bax/mitochondrial apoptosis signaling in the p53-independent mode, which is somewhat additive to the effects of p53. Bim-deficient mouse embryonic fibroblast (MEF) cells were resistant to the apoptotic effects of Myc, while loss of Bim accelerated lymphoma development. Furthermore, Bim was overexpressed at the same frequency in Myc-initiated lymphomas, irrespective of p53 status, suggesting that Bim resides in a pathway separate from p53. Loss of Bim further augmented resistance to apoptosis in p53 -/-MEFs. Mice with p53 knockdown exhibited exacerbated malignancies in the absence of Bim. The combined loss of these proteins promoted more severe spontaneous tumorigenesis. Thus, Myc-induced apoptotic signals through Bim and p53 must bifurcate to activate Bax, suggesting that the activation of Bim and p53 significantly contribute to apoptosis. Our results, therefore, establish that p53 and Bim are effective key initiators of apoptosis in lymphoma cells, particularly when combined.
Introduction
Over 30% of human tumors highly express the Myc proto-oncogene. Paradoxically, Myc plays a crucial role in cell proliferation and apoptosis (1, 2) . Aside from its cell proliferation activities, Myc is capable of inducing or sensitizing cells to apoptosis by inducing cytochrome c release that depends on caspase activation (3) . Impaired apoptosis of Myc is linked to lymphomagenesis in mice. Any mutations that prevent cells from undergoing apoptosis may be oncogenic, a phenomenon that is well documented but incompletely understood (4) (5) (6) .
It has been proposed that a group of BH3-only proteins may be involved during apoptosis in cells and this depend on oncogenic Myc. The BH3-only proapoptotic proteins are proven to be the major physiological antagonists of Bcl-2, which may mediate Myc-induced apoptosis of lymphoma cells (7) (8) (9) . During Myc-induced lymphomagenesis, the one protein most consistently implicated as cooperating with Myc is p53; however, apoptosis is attenuated but not completely suppressed when the p53 pathway is inactivated. While the significance of Bim and other genes has been recognized (10-12) during Myc-involved lymphomagenesis, independently of p53 (13) , it is unclear as to whether these genes are absolutely required for neoplastic growth or are merely selected during the late stages of tumor progression (14) . We hypothesized that the BH3-only members, particularly Bim, play a crucial role following Myc deregulated expression and might be potential novel apoptotic induction targets for future tumor intervention.
To determine whether Myc overexpression is capable of targeting Bim to promote tumorigenesis in mice, we used a system for rapidly generating tissue-specific transgenic mice to study Bim's role in Myc-induced apoptosis in lymphomagenesis. Notably, the additional loss of Bim (p53 independent) over p53 deficiency elevated the rate of spontaneous tumor development and resisted against drug-induced cell death, confirming the intrinsic tumor-suppressor potential of these proteins. Thus, constraining the cellular apoptotic program by genetic targeting of the BH3-only proapoptotic proteins, such as Bim, not only controls sensitivity of lymphoma cells to Myc but also determines therapeutic outcome.
Materials and methods

Primary mouse embryonic fibroblast (MEF) harvest and retroviral infection in vitro.
Primary MEFs were obtained from E13.5 embryos. Retroviral infections were carried out using murine stem cell virus (MSCV) vectors encoding green fluorescent protein (GFP) 3' of an internal ribosomal entry site (IRES) of a bicistronic message. MSCV-GFP and MSCV-GFP-WT MYC were kindly provided by S.W. Lowe. Murine Bim was cloned into pMSCV-IRES-GFP as a 761-bp BglII-EcoRI fragment (MSCV-Bim). Retroviral-mediated gene transfer was performed using Phoenix packaging cells, as previously described (1) . Aliquots of harvested MEFs (3x10 6 cells) were infected with MSCV-GFP, MSCV-GFP-WT MYC and MSCV-Bim through coculturing with high titer retroviral supernatants. Cocultures were incubated four times by spinoculation at 600 x g for 10 min in 3 ml of retroviral supernatant every 6-8 h. Growth factors were included in the suspension culture at the following concentrations: 20 ng/ml murine IL-3 (R&D Systems, Minneapolis, MN, USA), 50 ng/ml human IL-6 (R&D Systems), 50 ng/ml murine stem cell factor (SCF) (R&D Systems) and 2 µg/ml Polybrene (Sigma, St. Louis, MO, USA). A total of 24 h following the last infection, the fraction of GFP-expressing cells was measured by flow cytometry (FACScalibur, Beckton Dickinson).
Bone marrow reconstitution, lymphoma monitoring and analysis. The recipient C57BL/6 inbred strain of mice (6-8 weeks old) was lethally irradiated with a 10 Gy-dose of total body irradiation (TBI) (0.8 Gy/min) using a 60Co-γ ray source. Aliquots of 1-2x10 6 viable nucleated fetal liver cells in 0.5 ml or less of phosphate-buffered saline (PBS) were collected in 1-ml tuberculin syringes and infused slowly through the central tail vein of the recipients, as described previously (18) . Mice were housed on autoclaved bedding in air-filtered cages and received neomycin-containing drinking water. Radiation controls were simultaneously prepared to confirm the adequacy of the lethal irradiation dose. Animals were euthanized and monitored for illness by lymph node (LN) palpation and were monitored for overall morbidity. The occurrence of well-palpable peripheral LN enlargements defined the onset of lymphoma. Overall survival was defined at the time from stem cell reconstitution until the animal reached a terminal stage. Statistical evaluation of tumor onset is based on the log-rank test for comparison of the Kaplan-Meier event-time format. Reconstituted animals, harboring control and p53 -/-lymphomas, were, in some cases, subjected to whole-body fluorescence imaging. In certain cases, animals were also sacrificied at predetermined times by cervical dislocation. Spleens, lung, liver and tumor tissue were removed en bloc at necropsy, exsanguinated with PBS washing and placed on dry ice immediately in order to subject tissues to staining with hematoxylin and eosin (H&E). This method enables investigators to evaluate apoptotic nuclear morphology and the invasiveness of lymphoma cells into visceral organs. Lymphoma tissues were either fixed for histopathological evaluation or processed to single-cell suspensions for subsequent assays and cell culture.
Isolation and screening of lymphoma cells with Bim knockdown or transduction. Lymphoma-bearing mice were sacrificed by CO 2 euthanasia. LNs were dissected, minced in PBS and filtered through a 35-µm nylon mesh. Single cell suspensions of freshly harvested lymphomas were incubated on an irradiated (30 Gy) feeder layer (10 6 NIH-3T3 cells/2.4-cm plate) at 37˚C in a humidified atmosphere containing 5% CO 2 and immunophenotyped by flow cytometry using antibodies directed against B220 and immunoglobulin M (IgM) (Pharmingen, Franklin Lakes, NJ USA). The high-purity small interfering RNAs (siRNAs) SignalSilence ® Bim siRNA kit (Cell Signaling Technology, MA, USA) and control siRNA were purchased from Upstate (Charlottesville, VA, USA). The lipid encapsulated SMARTpool™ and control were used for transfection. At the time of transfection, the cell density was 70-90% confluent, or at a density of approximately 1x10 5 cells/ml. We transfected the cells using siRNAs with the siIMPORTER™ Transfection Reagent (Upstate), following the manufacturer's instructions and taking measures to test and optimize the conditions bestsuited for the cell line or culture of choice. To stably knock down the expression of Bim, we used the BLOCK-iT Inducible H1 Lentiviral RNAi System™, which was purchased from Invitrogen, according to the manufacturer's instructions (Invitrogen, CA, USA). The insert strand sequences of the short hairpin RNA (shRNA)-encoding oligonucleotides were 5'-GATCCCCCGTATGCGG AATACTTTGATTCAAGAGATCGAAGTATTCCGCGTA CGTTTTTC-3' for control (luciferase) and 5'-GATCCCCGA CTGAGAAGGTAGATAATTTTCAAGAGAAATTGTCTA CCTTCTCGGTCTTTTTC-3' for Bim. We transfected the lymphoma cells with 10 µl rat Bim-shRNA virus per well of a 12-well plate in the presence of polybrene (Fisher Scientific, Tustin, CA, USA) for adherent cells, following the manufacturer's instructions and taking measures to test and optimize the conditions best-suited for the cell line or culture of choice. Gene silencing effects were evaluated by Western blot analysis. For the construction of the tetracyclineregulated gene expression vectors expressing Bim, the coding region of mouse Bim was PCR-amplified and subcloned into pTHE vector, resulting in pTHE-Bim. All PCR-amplified fragments and cloning junctions were verified by DNA sequencing. Details regarding vector construction are available upon request. For in vitro drug assays, lymphoma cells with different genotypic backgrounds were subjected to cyclophosphamide (CTX) Pude Pharm. Corp., Shanxi, China) at a concentration of 20 µM for 4 h, and viability and apoptosis were measured 4 h later (see following section).
Western blot analysis. Lymphoma cell and MEFs harboring variant genotypes were incubated for 24 h in 0.1% fetal bovine serum (FBS) (low serum), lysed using protein extraction buffer and homogenized in 250 µl of lysis buffer. Cytoplasmic and mitochondrial extracts corresponding to 60 µg of protein (BioRad Bradford protein assay) were electrophoresed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on 4 to 20% gradient gels (Shanghai Sangon Biotech, Shanghai, China) and transferred to nylon membranes (Shanghai Sangon Biotech). The blots were probed with primary antibodies to recognize respective proteins, including anti-Bim against Bim-extra long (EL), Bim-long (L), Bim-short (S) (1:150, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Puma, anti-Myc (#sc-142), anti-Bcl-2, anti-phosphorylated Bcl-2 that recognizes epitope Ser 87 (1:40, Santa Cruz Biotechnology), anti-cleaved caspase 3 (Asp175) (1:100) and anti-cleaved caspase 9 (Asp330) (1:100; Cell Signaling Technology). Horseradish peroxidase-coupled mouse anti-rabbit immunoglobulin (Jingmei Biotech Co., Ltd., Shenzhen, China) secondary antibodies were subsequently incubated for 1 h at room temperature. The subsequent protein was analyzed with chemiluminescence using an ECL Western blotting kit (Amersham Biosciences, IL, USA), according to the manufacturer's instructions.
Lymphoma reconstitution and treatment. We transplanted uncultured or retrovirally infected lymphoma cells into syngeneic p53 knockdown and non-transgenic 6-to 10-week-old C57BL/6 mice by tail vein injection (10 6 viable lymphoma cells in PBS). Mice were fed 0.02 mg/ml tetracycline-containing drinking water every 4 days to activate the target Bim, and received a single intraperitoneal dose of 300 mg/kg body weight of CTX upon tumor manifestation. The recipient mice were monitored for tumor formation twice a week by palpation of the pre-scapular and cervical LNs. Enlargements of at least 5 mm in the longest diameter were considered 'well-palpable' and reflective of malignant disease. Tumor-transplanted mice were subjected to survival monitoring and histopathological evaluation, as described previously.
Assessment of viability and apoptosis. The viabilities of cultured serum starvation lymphoma cells, MEFs were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay using an ELISA reader (Anthos Mikrosysteme GmBH, Germany) at a wavelength of 570 nm. A standard optical density of the untreated control cells was considered at 100% viability to calculate the viability of the treated cells. The level of apoptosis was analyzed by a fluorescence-based terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. The commercially available APO-BrdU™ TUNEL assay kit (with Alexa Fluor ® 488 anti-BrdU, 60 assays) (Invitrogen) was utilized to label DNA fragmentation with terminal deoxynucleotide transferase following the instructions of the manufacturer. The FACS apoptotic cell analysis was quantified (Calibur, BD Biosciences, CA, USA) using the geo mean function of the CellQuest Software (FACScan, BD Biosciences). All flow cytometry analyses were repeated in triplicate.
Immunofluorescence and confocal assays. For immunostaining, the cells were fixed in 4% (v/v) paraformaldehyde for 10 min at room temperature, permeabilized in 0.1% Triton X-100 solution for 10 min and stained with primary anti-Bax antibodies (1:200, Santa Cruz Biotechnology) and anti-cytochrome c (1:200, Cell Signaling Technology) for 30 min at room temperature. Following washing with PBS, cells were incubated with affinity-purified FITC-or rhodamine-conjugated secondary antibodies (mouse anti-rabbit IgG, 1:4000, Jackson Immuno Research, West Grove, PA, USA). Following 1 h of incubation, slides were mounted and the stained cells were analyzed under a confocal microscope (Leica Microsystems Heidelberg GmbH, Heidelberg, Germany) at an excitation of 488 nm and emission of 525 nm.
Mouse footpad injections and in vivo imaging. Mouse footpad injections were performed as described previously. In a typical experiment, a total volume of 50 µl PBS, containing 10 µg Bim siRNA or pTHE-Bim with 10 µg of expression plasmid, was intradermally injected into a mouse footpad. At the indicated points in time, the mice were imaged 10 min following intraperitoneal injection of luciferin (100 µl of 30 mg/ml luciferin; 150 mg/kg body weight). Mice were sedated using isoflurane and live anesthetized mice were imaged using the IVIS100 in vivo imaging system (Xenogen Corp., Alameda, CA, USA). The resulting light emission was quantified using LivingImage software (Xenogen Corp), written as an overlay on Igor image analysis software (WaveMetrics Inc., Lake Oswego, OR, USA). Raw values are reported as photons/sec/cm 2 /sr.
Results
Bim is critical but is not the sole BH3-only protein mediating
Myc-induced apoptosis. We hypothesized that Bim plays a crucial role following deregulated expression of Myc and represent a potential novel apoptotic induction target for tumor intervention. To discriminate this and evaluate the extent of its contribution, we studied the expression of Bim in MEFs followed by Myc infection. Immunoblot analysis revealed that the levels of all three major splicing isoforms (Bim EL, Bim L and Bim S) were induced following Myc infection in both MEFs but not in the normal control. Moreover, Myc appeared to induce significant dephosphorylation of Bim EL (Fig. 1A) . 
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This finding is notable because others have shown that dephosphorylation of Bim increases its proapoptotic function (7). We further examined the proapoptotic effect of Bim through transfection of Bim in MEF cells. Myc transfection for 24 h in MEFs induced cell apoptosis by approximately 21%; further introduction of Bim for 24 h enhanced the inhibitory effects by almost 39%, as compared to the apoptosis rate (Fig. 1B) . The up-regulation of Bim was not attenuated in p53 -/-MEFs following Myc infection (Fig. 1B) , suggesting that p53 deficiency does not completely mask the Myc-induced apoptosis signal. When we silenced Bim in p53 -/-MEFs, the inhibition effect attained maximum values, as indicated in Fig. 1B . By comparison, cells transfected with control siRNA against GFP continued to undergo apoptosis in response to Myc; levels were similar in cells that did not receive siRNA.
Bim-dependent apoptosis is involved in Bax/mitochondrial apoptosis signaling. Myc-transduced tissue-specific transgenic mice were identified histopathologically ( Fig. 2A) . Lymphoma cells were isolated and apoptosis was measured in a series of matched controls, Bim-overexpressing and silenced lymphomas cells. Cells were then subjected to serum starvation in order to trigger apoptosis. Lymphoma cells overexpressing Bim were capable of releasing cytochrome c from mitochondria, altering localization of the proapoptotic protein, Bax, and inducing caspase activation, as indicated by Western blots for caspases 3 and 9. These caspases may be blocked by the caspase inhibitor z-VAD-fmk (Fig. 2B) . Using the methods of immunostaining by confocal microscopy, we found that Bax alone displayed a nuclear staining pattern in the lymphoma cells. Following transfection with Bim, Bax was found in the cytoplasm in apoptotic cells, indicating its activition by Bim. In the meantime, the distribution of cytochrome c changed from punctate to more diffuse, verifying the release of cytochrome c from mitochondria (Fig. 2C ). In addition, there was some overlap observed between Bax and cytochrome c staining by merging their images. This was further verified through the measurement of cytochrome c in the cytoplasm using methods previously described. These observations suggest that Bax translocates to mitochondria during Bim-induced apoptosis in lymphoma cells. In addition, concomitant with synergistic toxicity, Bim plus p53 could also increased cytochrome c release in our system more than Bim alone (Fig. 2C) , indicating that cellular inhibition of Bim or p53 is primarily through cascade and mitochondrial pathways. Such a mechanism is consistent with the finding that Bim and p53 may act in concert in response to gamma-radiation and glucocorticoids (20) .
Loss of Bim accelerates morbidity in mice with Myc-induced lymphoma.
In order to evaluate the apoptotic effect of Bim on lymphomas in vivo, we investigated whether loss of Bim was capable of accelerating lymphoma penetrance. Firstly, we designed and produced lentiviral vectors that expressed a shRNA targeting Bim and a control sequence. An infection rate of almost 100% was achieved in the lymphomas, and the provirus vector was stably integrated as indicated by the expression of a GFP marker that was encoded by the lentivirus, and remained constant and complete in the Bim shRNA-infected lymphoma population 8 weeks following infection (Fig. 3A) . Western blot analysis revealed effective Bim silencing (the reduction in the expression of Bim) in both the basal state and when lymphomas were transplanted into recipient mice (Fig. 3B) . Consistent with the histopathological findings, whole-body fluorescence imaging, with more dissemination, was used to observe an aggressive invasive growth pattern, including the liver, kidneys, lung and brain in Bim knockdown and p53-null lymphomas. Tumor cells were restricted to the LN, bone marrow and spleen in controls, despite a similarly large tumor burden (Fig. 3C) . Control lymphoma cells developed a follicular lymphoma stochastically when transplanted into recipient mice at a low penetrance following a long latency period of >3 months (the latency was 66±21 days); only 5 of the 15 monitored mice developed a tumor. However, when Bim deficiency was present we observed a striking acceleration of penetrance: 13 out of the 15 observed mice developed tumors (P<0.005 for Bim loss vs. control) and exhibited a significantly reduced latency (38±16 days). Mice with Bim knockdown that were p53-null formed tumors relatively rapidly, with an identical high penetrance (15 out of 15 mice developed tumors) and a short latency (33±18 days) (Fig. 3D) . As expected, mice harboring both Bim knockdown and p53-null lymphoma displayed decreased survival time, with tumor cells that disseminated frequently and extensively into non-lymphoid organs. Bim is capable of prolonging the survival of lymphomabearing mice. We next measured the ability of Bim to prolong the survival of lymphoma-bearing mice. We transplanted pTHE-Bim-infected and uninfected lymphoma cells derived from the same primary lymphoma into recipients, fed the mice with tetracycline-containing drinking water to trigger Bim expression and then monitored the palpable lymphoma masses twice a week. Following transplantation, 48% of the Bim-overexpressing lymphomas failed to present palpable LNs during the period of observation. The median survival of Bim-transfected mice was significantly extended compared with uninfected, directly transplanted counterparts (86±39 days for Bim transduction and 32±11 days for control) (Fig. 4A , P= 0.005). Lymphoma restriction followed by Bim overexpression was further visualized using whole-body fluorescence imaging (Fig. 4B) , which indicated that lymphoma inhibition was driven by the introduced proapoptotic Bim gene. Moreover, autopsy of vehicle-treated mice revealed disseminated disease throughout the lymphoid system with enlarged LNs and splenomegaly. Bim-overexpessing mice autopsied at the same time and assessed by TUNEL assay displayed a dramatic increase in apoptotic cells (Fig. 4C ).
Bim has a profound effect on drug-induced cell death in vitro and in vivo. The p53
-/-mice were used as recipients to generate Myc-induced lymphomas. The isolated lymphoma cells were then subjected to Bim siRNA to establish a cohort of lymphoma cells containing Bim and p53 double-deficient plus all relevant controls. The cells were then challenged with various cytotoxic agents, respectively, in particular with CTX. ( Fig. 5) . Expression of Bim in p53 -/-cells partly restored the susceptibility of these cells to the chemotherapy agent CTX as described previously. This indicates that Bim and p53 have overlapping roles in the chemotherapy agent-induced killing of lymphoma cells. Thus, we can conclude that Bim loss has a potent anti-apoptotic effect following treatment in isolated lymphoma cells.
Discussion
In this study, by comparing the properties of Myc-induced lymphomas from a number of genetic backgrounds, we extended the observation of the proapoptotic Bcl-2 family member, Bim, a major regulator of lymphoid and myeloid homeostasis and showed that Bim is a key apoptotic effector of Myc in sensitizing cells with Myc-induced cell apoptosis. Bim deletions may impact tumor development and anticancer therapy. In addition, activation of Bim is essential for tumor cell killing and critical for the Myc-Bcl-2 signaling cascade. Furthermore, we demonstrated that cooperative effects between p53 and Bim loss contribute to the marked Myc sensitivity of lymphomagenesis.
Bim has been proven to be a proapoptotic target of Myc, and loss of p53 is unable to suppress Bim expression in certain cell types. In this report, Myc was capable of inducing the proapoptotic BH3 protein, Bim, while deficient Bim activity was able to impair Myc-mediated apoptosis. Bim overexpression resulted in enhanced cell death and growth inhibition in response to the Myc oncogene, suggesting that Bim is essential for the initiation of Myc-induced apoptosis. Similar dependence on Bim for apoptosis by other cancer cells has also been observed (15) (16) (17) . Although the elevated level of Bim in MEF cells suggests that Bim is a proapoptotic target of Myc, we have, until now, been unable to demonstrate any direct activation of Bim by Myc.
This raises the possibility that the loss of Bim consequently accelerates Myc-induced lymphomagenesis. To confirm and extend the effects of Bim to Myc-induced lymphoma, we examined the impact of Bim expression or silencing on Myc-induced lymphoma development or apoptosis of isolated lymphoma cells following short-term culture through a system for rapidly generating tissue-specific transgenic mice. Such animals develop B-cell lymphomas a number of months later. This model provided a candidate screen to identify the apoptotic proteins. First, various combinations of transgenes or stem cell genotypes may be easily created, providing a relevant setting for rapidly comparing the impact of Myc and Bim on tumor behavior. Second, all of the altered genes are capable of being easily monitored, a property that facilitates examining signal transduction for apoptosis. In addition, essentially pure tumor cells may be isolated from LNs and studied ex vivo by retrovirally transducing primary lymphomas to overexpress a gene of interest. These cells may also be expanded in genetically matched nontransgenic recipients (18, 19) .
In order to generate a cohort of lymphoma cells containing Bim and p53 double-deficiency in vivo, viable selected stable Bim-silenced lymphoma cells were immediately transplanted into the tail vein of syngeneic mice recipients, wherein they were allowed to expand in vivo. Endogenous Bim expression was confirmed to be attenuated with Bim siRNA, while Bim was unaffected in control mice. This method provided a rapid alternative for generating complex tumor genotypes. These lymphomas were histopathologically identical to their respective primary tumors when aliquots of the same population were propagated in separate recipients (21, 27) .
Either Bim or p53 loss in lymphomas appears to be indispensable for the aggressive behavior of lymphoma. Further evidence obtained through TUNEL assay in the current study indicated that apoptosis was involved in Bim-induced cell death, independent of p53. We also observed that the up-regulation of Bim determines the sensitivity of lymphoma cells to the apoptotic effects of certain chemotherapy agents. Although it has been previously indicated that p53 is capable of cooperating with Bim to play a role in apoptosis induction (26) , the data presented herein provide compelling evidence that, while p53 induction is required for Myc-induced apoptosis, it may not be sufficient to provoke cell death and that Bim is essential for the apoptosis elicited in lymphoma cells harboring Myc activation. Indeed, this study provides formal genetic proof that Bim and p53 may present different targets of Myc. Similarly, Bim may reside in a position in the pathway that does not influence p53, Bim and p53 must function in separate pathways. Therefore, although Bim and p53 may function in the same tumorsuppressor pathway of Myc-Bax, our results demonstrate that this pathway must bifurcate. There is cooperativity between Bim and p53 at least at some level. Understanding how the involved signaling components work would provide critical information to help design strategies to augment their efficacy.
One of the most intriguing outcomes of this study is that we confirmed and extended the signal network by linking Myc with p53 and Bim. There is a cooperative effect on the rate of tumorigenesis in mice lacking p53 with silenced Bim in comparison to mice deficient in p53 alone. This implies that Bim does synergize the p53 functions involved in the proliferation ability of lymphoma, although we have not yet analyzed the secondary changes of Bim and p53 loss in detail. In this context, it could be possible that the enhancement of Bim and p53 expression or simultaneous activation of downstream targets might be a promising strategy for the treatment of lymphoma, particularly in the context of conventional theraputic resistance. Conventional therapies mainly rely on activating the cell death program indirectly and it seems likely that strategies that could directly activate cell-suicide machinery would be more effective (22) . It has been verified that BH3 mimetics, such as ABT-737, substantially enhanced apoptosis in a number of types of the tested cells (23, 24) . The search for BH3 mimetics specifically targeted to both Bim and p53 signals is intensifying and some promising leads are beginning to emerge.
